196
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Occurrence and characterization of lipofuscin and ceroid in human atherosclerotic plaque

Pages 477-488 | Received 06 Aug 2018, Accepted 02 Nov 2018, Published online: 22 Nov 2018

References

  • Pesonen E. Extrinsic and intrinsic factors relating to intimal thickening in children. Acta Paediatr Suppl. 2004;446:43–47.
  • Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association. Circulation. 1995;92:1355–1374.
  • Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association. Circulation. 1994;89:2462–2478.
  • Stary HC. Changes in components and structure of atherosclerotic lesions developing from childhood to middle age in coronary arteries. Basic Res Cardiol. 1994;1:17–32.
  • Perrotta I. Ultrastructural features of human atherosclerosis. Ultrastruct Pathol. 2013;37:43–51. doi:10.3109/01913123.2011.592721.
  • MacLeod DC, Strauss BH, de Jong M, et al. Proliferation and extracellular matrix synthesis of smooth muscle cells cultured from human coronary atherosclerotic and restenotic lesions. J Am Coll Cardiol. 1994;23:59–65.
  • Walski M, Chlopicki S, Celary-Walska R, Frontczak-Baniewicz M. Ultrastructural alterations of endothelium covering advanced atherosclerotic plaque in human carotid artery visualised by scanning electron microscope. J Physiol Pharmacol. 2002;53:713–723.
  • Lusis AJ. Genetics of Atherosclerosis. Trends Genet. 2012;28:267–275. doi:10.1016/j.tig.2012.03.001.
  • Lindner J. New morphological and biochemical aspects of atherosclerosis. Pathol Res Pract. 1985;180:329–335. doi:10.1016/S0344-0338(85)80100-X.
  • Di Guardo G. Lipofuscin, Lipofuscin-Like Pigments and Autofluorescence. Eur J Histochem. 2015;59:2485. doi:10.4081/ejh.2015.2485.
  • Goldfischer S, Bernstein J. Lipofuscin (aging) pigment granules of the newborn human liver. J Cell Biol. 1969;42:253–261.
  • Mink JW, Augustine EF, Adams HR, Marshall FJ, Kwon JM. Classification and natural history of the neuronal ceroid lipofuscinoses. J Child Neurol. 2013;28:1101–1105. doi:10.1177/0883073813494268.
  • Sinha S, Satishchandra P, Santosh V, Gayatri N, Shankar SK. Neuronal ceroid lipofuscinosis: a clinicopathological study. Seizure. 2004;13:235–240. doi:10.1016/S1059-1311(03)00163-8.
  • Giaccone G, Orsi L, Cupidi C, Tagliavini F. Lipofuscin hypothesis of Alzheimer’s disease. Dement Geriatr Cogn Dis Extra. 2011;1:292–296. doi:10.1159/000329544.
  • Kellner U, Kellner S, Weber BH, Fiebig B, Weinitz S, Ruether K. Lipofuscin- and melanin-related fundus autofluorescence visualize different retinal pigment epithelial alterations in patients with retinitis pigmentosa. Eye (Lond). 2009;23:1349–1359. doi:10.1038/eye.2008.280.
  • Lambert JR, Luk SC, Pritzker KP. Brown bowel syndrome in Crohn’s disease. Arch Pathol Lab Med. 1980;104:201–205.
  • Shields JA, Rodrigues MM, Sarin LK, Tasman WS, Annesley WH Jr. Lipofuscin pigment over benign and malignant choroidal tumors. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1976;81:871–881.
  • Monserrat AJ, Benavides SH, Berra A, Fariña S, Vicario SC, Porta EA. Lectin histochemistry of lipofuscin and certain ceroid pigments. Histochem Cell Biol. 1995;103:435–445.
  • Ward JM, Reznik-Schüller H. Morphological and histochemical characteristics of pigments in aging F344 rats. Vet Pathol. 1980;17:678–685. doi:10.1177/030098588001700604.
  • Kiselyov K, Jennigs JJ Jr, Rbaibi Y, Chu CT. Autophagy, mitochondria and cell death in lysosomal storage diseases. Autophagy. 2007;3:259–262.
  • Kurz T, Terman A, Gustafsson B, Brunk UT. Lysosomes in iron metabolism, ageing and apoptosis. Histochem Cell Biol. 2008;129:389–406. doi:10.1007/s00418-008-0394-y.
  • Haka AS, Kramer JR, Dasari RR, Fitzmaurice M. Mechanism of ceroid formation in atherosclerotic plaque: in situ studies using a combination of Raman and fluorescence spectroscopy. J Biomed Opt. 2011;16:011011.
  • Joris I, Billingham ME, Underwood JM, Majno G. Lipofuscin and lipid oxidation in human coronary endothelium. Cardiovasc Pathol. 1998;7:75–85. doi:10.1016/S1054-8807(97)00076-8.
  • Yamada S, Kumazawa S, Ishii T, et al. Immunochemical detection of a lipofuscin-like fluorophore derived from malondialdehyde and lysine. J Lipid Res. 2001;42:1187–1196.
  • Carpenter KL, van der Veen C, Taylor SE, et al. Macrophages, lipid oxidation, ceroid accumulation and alpha-tocopherol depletion in human atherosclerotic lesions. Gerontology. 1995;2:53–67. doi:10.1159/000213725.
  • Grundy SM. Atherosclerosis: pathology, pathogenesis, and role of risk factors. Dis Mon. 1983;29:1–58.
  • Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H. Atherosclerosis: process, indicators, risk factors and new hopes. Int J Prev Med. 2014;5:927–946.
  • Uryga AK, Bennett MR. Ageing induced vascular smooth muscle cell senescence in atherosclerosis. J Physiol. 2016;594:2115–2124. doi:10.1113/JP270923.
  • Childs BG, Baker DJ, Wijshake T, Conover CA, Campisi J, van Deursen JM. Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science. 2016;354:472–477. 28. doi:10.1126/science.aaf6659.
  • Bennett MR, Clarke MC. Basic research: killing the old: cell senescence in atherosclerosis. Nat Rev Cardiol. 2016;14:8–9. doi:10.1038/nrcardio.2016.195.
  • Johansson B. Cellular senescence and atherosclerosis. Med Hypotheses. 1984;14:115–124.
  • Tesauro M, Mauriello A, Rovella V, et al. Arterial ageing: from endothelial dysfunction to vascular calcification. J Intern Med. 2017;281:471–482. doi:10.1111/joim.12605.
  • Xu X, Wang B, Ren C, et al. Age-related Impairment of Vascular Structure and Functions. Aging Dis. 2017;8:590–610. doi:10.14336/AD.2017.0430.
  • Brunk UT, Terman A. The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur J Biochem. 2002;269:1996–2002.
  • Carmona-Gutierrez D, Hughes AL, Madeo F, Ruckenstuhl C. The crucial impact of lysosomes in aging and longevity. Ageing Res Rev. 2016;32:2–12. doi:10.1016/j.arr.2016.04.009.
  • Brunk UT, Terman A. Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radic Biol Med. 2002;33:611–619.
  • Höhn A, Grune T. Lipofuscin: formation, effects and role of macroautophagy. Redox Biol. 2013;1:140–144. doi:10.1016/j.redox.2013.01.006.
  • Sulzer D, Mosharov E, Talloczy Z, Zucca FA, Simon JD, Zecca L. Neuronal pigmented autophagic vacuoles: lipofuscin, neuromelanin, and ceroid as macroautophagic responses during aging and disease. J Neurochem. 2008;106:24–36. doi:10.1111/j.1471-4159.2008.05385.x.
  • Goyal VK. Lipofuscin pigment accumulation in human brain during aging. Exp Gerontol. 1982;17:481–487.
  • Goyal VK. Lipofuscin pigment accumulation in the central nervous system of the mouse during aging. Exp Gerontol. 1982;17:89–94.
  • Boellaard JW, Schlote W, Hofer W. Species-specific ultrastructure of neuronal lipofuscin in hippocampus and neocortex of subhuman mammals and humans. Ultrastruct Pathol. 2004;28:341–351. doi:10.1080/019131290882330.
  • Hayashi H, Winship DH, Sternlieb I. Lipolysosomes in human liver: distribution in livers with fatty infiltration. Gastroenterology. 1977;73:651–654.
  • Haimi M, Iancu TC, Shaffer LG, Lerner A. Severe lysosomal storage disease of liver in del(1)(p36): a new presentation. Eur J Med Genet. 2011;54:209–213. doi:10.1016/j.ejmg.2010.11.012.
  • Iancu TC, Manov I, Shaoul R, Haimi M, Lerner A. What’s in a name?-”Lipolysosome”: ultrastructural features of a lipid-containing organelle. Ultrastruct Pathol. 2013;37:293–303. doi:10.3109/01913123.2013.799625.
  • Harman D. Lipofuscin and ceroid formation: the cellular recycling system. In: Porta EA, ed. Lipofuscin and Ceroid Pigments. New York: Plenum Press; 1990:3–15.
  • Nixon RA, Cataldo AM, Paskevich PA, Hamilton DJ, Wheelock TR, Kanaley-Andrews L. The lysosomal system in neurons. Involvement at multiple stages of Alzheimer’s disease pathogenesis. Ann NY Acad Sci. 1992;674:65–88.
  • Dowson JH. Neuronal lipofuscin accumulation in ageing and alzheimer dementia: a pathogenic mechanism? Br J Psychiatry. 1982;140:142–148.
  • Zakliczynski M, Nozynski J, Konecka-Mrowka D, et al. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy? J Thorac Cardiovasc Surg. 2009;138:215–221. doi:10.1016/j.jtcvs.2009.02.040.
  • Terman A, Dalen H, Eaton JW, Neuzil J, Brunk UT. Aging of cardiac myocytes in culture: oxidative stress, lipofuscin accumulation, and mitochondrial turnover. Ann N Y Acad Sci. 2004;1019:70–77. doi:10.1196/annals.1297.015.
  • Ošťádalová I, Charvátová Z, Wilhelm J. Lipofuscin-like pigments in the rat heart during early postnatal development: effect of selenium supplementation. Physiol Res. 2010;59:881–886.
  • Mitchinson MJ, Ball RY, Carpenter KLH, Parums DV. Macrophages and ceroid in atherosclerosis. In: Suckling KE, Groot PH, eds. Hyperlipidaemia and Atherosclerosis. London: Academic Press; 1988:117–134.
  • Mitchinson MJ. Insoluble lipids in human atherosclerotic plaques. Atherosclerosis. 1982;45:11–15.
  • Mitchinson MJ, Hothersall DC, Brooks PN, De Burbure CY. The distribution of ceroid in human atherosclerosis. J Pathol. 1985;145:177–183. doi:10.1002/path.1711450205.
  • Burt RC. The incidence of acid-fast pigment (ceroid) in aortic atherosclerosis. Am J Clin Pathol. 1952;22:135–139.
  • Fossale E, Wolf P, Espinola JA, et al. Membrane trafficking and mitochondrial abnormalities precede subunit c deposition in a cerebellar cell model of juvenile neuronal ceroid lipofuscinosis. BMC Neurosci. 2004;5:57. doi:10.1186/1471-2202-5-25.
  • Terman A, Abrahamsson N, Brunk UT. Ceroid/lipofuscin-loaded human fibroblasts show increased susceptibility to oxidative stress. Exp Gerontol. 1999;34:755–770.
  • Porta EA. Pigments in aging: an overview. Ann N Y Acad Sci. 2002;959:57–65.
  • Katz ML, Robison WG Jr. What is lipofuscin? Defining characteristics and differentiation from other autofluorescent lysosomal storage bodies. Arch Gerontol Geriatr. 2002;34:169–184.
  • Siegismund G, Goebel HH, Löblich HJ. Ultrastructure and visceral distribution of lipopigments in infantile neuronal ceroid-lipofuscinosis. Pathol Res Pract. 1982;175:335–347.
  • Boldrini R, Biselli R, Santorelli FM, Bosman C. Neuronal ceroid lipofuscinosis: an ultrastructural, genetic, and clinical study report. Ultrastruct Pathol. 2001;25:51–58.
  • Elleder M. A histochemical and ultrastructural study of stored material in neuronal ceroid lipofuscinosis. Virchows Arch B Cell Pathol. 1978;28:167–178.
  • Mitchinson MJ. Macrophages, oxidised lipids and atherosclerosis. Med Hypotheses. 1983;12:171–178.
  • Lee FY, Lee TS, Pan CC, Huang AL, Chau LY. Colocalization of iron and ceroid in human atherosclerotic lesions. Atherosclerosis. 1998;138:281–288.
  • Terman A, Kurz T, Gustafsson B, Brunk UT. The involvement of lysosomes in myocardial aging and disease. Curr Cardiol Rev. 2008;4:107–115. doi:10.2174/157340308784245801.
  • Brunk UT, Wihlmark U, Wrigstad A, Roberg K, Nilsson SE. Accumulation of lipofuscin within retinal pigment epithelial cells results in enhanced sensitivity to photo-oxidation. Gerontology. 1995;41:201–212. doi:10.1159/000213743.
  • Wolf G. Lipofuscin and macular degeneration. Nutr Rev. 2003;61:342–346.
  • Nakae Y, Stoward PJ, Kashiyama T, et al. Early onset of lipofuscin accumulation in dystrophin-deficient skeletal muscles of DMD patients and mdx mice. J Mol Histol. 2004;35:489–499.
  • von Zglinicki T, Nilsson E, Döcke WD, Brunk UT. Lipofuscin accumulation and ageing of fibroblasts. Gerontology. 1995;41:95–108. doi:10.1159/000213728.
  • Terman A. Garbage catastrophe theory of aging: imperfect removal of oxidative damage? Redox Rep. 2001;6:15–26. doi:10.1179/135100001101535996.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.